Milliman Healthcare Inflation Plus ETF MHIP
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 0.55%
- Net assets
- $994K
- Holdings
- 72
- 12-month distribution yield
- Unavailable
- Asset class
- Multi-asset
Milliman Healthcare Inflation Plus ETF (MHIP) is an exchange-traded fund listed on NYSE Arca in the United States. Its category is Multi-asset · US (multi-asset). Its last price was US$21.09 on 20 Oct 2026. Its net expense ratio is 0.55% a year, from its prospectus dated 17 Apr 2026. It reported net assets of US$994,139 as of 30 Jun 2026. Its latest holdings report lists 72 holdings as of 30 Jun 2026. No distributions are recorded for it over the last 12 months.
Fees
- Total annual operating expenses (gross)
- 0.56%
- Net, after fee waivers or reimbursements
- 0.55%
- Management fee
- 0.55%
- Prospectus date
- 17 Apr 2026
- Filed with the SEC
- 17 Apr 2026
Size and reporting
- Net assets
- $994,139
- Total assets
- $994,887
- Holdings as of
- 30 Jun 2026
- Report made public
- 26 Aug 2026 (57 days after the month end)
Top holdings
Largest 25 of 72 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | TREASURY BILL United States Treasury Bill | US912797UQ82 | 25.92% | $258K | Debt | United States | USD |
| 2 | BondBloxx Bloomberg Five Year BondBloxx Bloomberg Five Year Target Duration US Treasury ETF | US09789C8385 | 11.49% | $114K | Equity (common) | United States | USD |
| 3 | State Street SPDR Portfolio S& State Street SPDR Portfolio S&P 500 ETF | US78464A8541 | 8.80% | $88K | Equity (common) | United States | USD |
| 4 | BondBloxx Bloomberg Six Month BondBloxx Bloomberg Six Month Target Duration US Treasury ETF | US09789C7882 | 4.54% | $45K | Equity (common) | United States | USD |
| 5 | Eli Lilly & Co | US5324571083 | 4.34% | $43K | Equity (common) | United States | USD |
| 6 | UnitedHealth Group Inc | US91324P1021 | 3.76% | $37K | Equity (common) | United States | USD |
| 7 | Johnson & Johnson | US4781601046 | 2.66% | $26K | Equity (common) | United States | USD |
| 8 | Thermo Fisher Scientific Inc | US8835561023 | 2.62% | $26K | Equity (common) | United States | USD |
| 9 | Abbott Laboratories | US0028241000 | 2.18% | $22K | Equity (common) | United States | USD |
| 10 | SPDR Gold Shares | No identifier reported | 2.13% | $21K | Equity derivatives | United States | USD |
| 11 | Intuitive Surgical Inc | US46120E6023 | 2.00% | $20K | Equity (common) | United States | USD |
| 12 | Danaher Corp | US2358511028 | 1.88% | $19K | Equity (common) | United States | USD |
| 13 | Stryker Corp | US8636671013 | 1.68% | $17K | Equity (common) | United States | USD |
| 14 | Merck & Co Inc | US58933Y1055 | 1.56% | $16K | Equity (common) | United States | USD |
| 15 | Medtronic PLC | IE00BTN1Y115 | 1.40% | $14K | Equity (common) | Ireland | USD |
| 16 | CVS Health Corp | US1266501006 | 1.29% | $13K | Equity (common) | United States | USD |
| 17 | AbbVie Inc | US00287Y1091 | 1.11% | $11K | Equity (common) | United States | USD |
| 18 | Boston Scientific Corp | US1011371077 | 0.92% | $9K | Equity (common) | United States | USD |
| 19 | McKesson Corp | US58155Q1031 | 0.91% | $9K | Equity (common) | United States | USD |
| 20 | HCA Healthcare Inc | US40412C1018 | 0.90% | $9K | Equity (common) | United States | USD |
| 21 | Elevance Health Inc | US0367521038 | 0.86% | $9K | Equity (common) | United States | USD |
| 22 | Bristol-Myers Squibb Co | US1101221083 | 0.85% | $8K | Equity (common) | United States | USD |
| 23 | Cigna Group/The | US1255231003 | 0.75% | $7K | Equity (common) | United States | USD |
| 24 | Edwards Lifesciences Corp | US28176E1082 | 0.72% | $7K | Equity (common) | United States | USD |
| 25 | Becton Dickinson & Co | US0758871091 | 0.59% | $6K | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 71.94% | |
| Debt | 25.92% | |
| Equity derivatives | 2.10% | |
| Short-term investment vehicles (cash funds) | 0.04% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 98.60% | |
| Ireland | 1.40% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 100.01% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 37.42% | |
| Industrials | 6.08% | |
| Consumer Staples | 1.29% | |
| Technology | 0.43% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
No distributions in the last five years
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000101079) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- MHIP and FREI Fidelity Real Estate Income ETF
- MHIP and AOR iShares Core 60/40 Balanced Allocation ETF
- MHIP and AOA iShares Core 80/20 Aggressive Allocation ETF
- MHIP and AOM iShares Core 40/60 Moderate Allocation ETF